[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BRPI0921617A2 - Composicao nutricional compreendendo probioticos e padroes do sono aperfeicoados - Google Patents

Composicao nutricional compreendendo probioticos e padroes do sono aperfeicoados

Info

Publication number
BRPI0921617A2
BRPI0921617A2 BRPI0921617-0A BRPI0921617A BRPI0921617A2 BR PI0921617 A2 BRPI0921617 A2 BR PI0921617A2 BR PI0921617 A BRPI0921617 A BR PI0921617A BR PI0921617 A2 BRPI0921617 A2 BR PI0921617A2
Authority
BR
Brazil
Prior art keywords
probiotics
nutritional composition
sleep patterns
improved sleep
improved
Prior art date
Application number
BRPI0921617-0A
Other languages
English (en)
Inventor
Gabriela Bergonzelli Degonda
Isabelle Bureau-Franz
Clara Lucia Garcia-Rodenas
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40785276&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0921617(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0921617A2 publication Critical patent/BRPI0921617A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/742Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Anesthesiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI0921617-0A 2008-11-03 2009-10-29 Composicao nutricional compreendendo probioticos e padroes do sono aperfeicoados BRPI0921617A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08168161 2008-11-03
PCT/EP2009/064276 WO2010060722A1 (en) 2008-11-03 2009-10-29 A nutritional composition comprising probiotics and improving sleep patterns

Publications (1)

Publication Number Publication Date
BRPI0921617A2 true BRPI0921617A2 (pt) 2015-08-18

Family

ID=40785276

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921617-0A BRPI0921617A2 (pt) 2008-11-03 2009-10-29 Composicao nutricional compreendendo probioticos e padroes do sono aperfeicoados

Country Status (16)

Country Link
US (3) US9034314B2 (pt)
EP (2) EP2352393A1 (pt)
CN (2) CN102960447A (pt)
AU (1) AU2009319257B2 (pt)
BR (1) BRPI0921617A2 (pt)
CA (1) CA2742476A1 (pt)
CL (2) CL2011000891A1 (pt)
ES (1) ES2771176T3 (pt)
MX (1) MX2011004142A (pt)
MY (1) MY160376A (pt)
PH (1) PH12014501749A1 (pt)
PT (1) PT2438821T (pt)
RU (2) RU2642301C9 (pt)
TW (1) TW201029583A (pt)
WO (1) WO2010060722A1 (pt)
ZA (1) ZA201206546B (pt)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1012849A2 (pt) * 2009-05-11 2018-06-19 Nestec Sa lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes
JP5923238B2 (ja) * 2010-07-07 2016-05-24 アサヒグループホールディングス株式会社 迷走神経活性化剤
AU2012221154B2 (en) * 2011-02-23 2015-12-10 Biogaia Ab Indirect substrates for microorganisms metabolizing 1,2-propanediol
ES2677850T3 (es) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Composiciones y métodos probióticos
EP2708145B1 (en) * 2012-09-14 2016-05-04 Abbott Laboratories Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals
EP2708147B1 (en) 2012-09-14 2020-03-11 Abbott Laboratories Methods for increasing brain functionality using 2-fucosyl-lactose
PT2994150T (pt) 2013-05-10 2019-06-14 Heinz Co Brands H J Llc Probióticos e métodos de utilização
GB201319531D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
GB201319538D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
GB201319539D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
GB201319540D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
PL235821B1 (pl) * 2014-11-04 2020-11-02 Geo Poland Spolka Z Ograniczona Odpowiedzialnoscia Wysokoprolinowy kompleks peptydowy do zastosowania w profilaktyce i wspomaganiu leczenia zaburzeń i stanów wymagających podwyższania i/lub modulacji poziomu neurotropowego czynnika pochodzenia mózgowego jako oznaczonego w osoczu krwi biomarkera i zawierający go preparat
CN108367033A (zh) * 2015-08-31 2018-08-03 雀巢产品技术援助有限公司 使用长双歧杆菌治疗或预防抑郁症状的方法和组合物
CA2994347A1 (en) * 2015-08-31 2017-03-09 Nestec S.A. Methods and compositions using bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances
BR112018001179A2 (pt) * 2015-08-31 2018-09-11 Nestec Sa métodos e composições usando bifidobacterium longum para otimizar a amamentação
WO2017131402A1 (ko) * 2016-01-28 2017-08-03 경희대학교 산학협력단 면역조절 작용을 가는 사람 소화관 유래 신규 유산균 및 이의 용도
DK3442547T3 (da) 2016-04-15 2023-09-04 Baylor College Medicine Lactobacillus reuteri MM4-1A til anvendelse i behandling eller forebyggelse af autismespektrumforstyrrelser
ES2969755T3 (es) * 2016-07-01 2024-05-22 Nestle Sa Composición nutricional que comprende un probiótico para la prevención y/o el tratamiento de trastornos de ansiedad y depresión en un mamífero
KR20180019474A (ko) 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
CN110520142A (zh) * 2017-05-05 2019-11-29 雀巢产品有限公司 婴儿腹绞痛的治疗
EP3629768A1 (en) 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. A nutritional composition for use to enhance attention and/or reduce impulsivity
MY197900A (en) 2017-06-02 2023-07-24 Univ Of Otago Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
US11439675B2 (en) 2017-07-07 2022-09-13 President And Fellows Of Harvard College Method for treating damage induced by sleep deprivation
EP3664894B1 (fr) 2017-08-11 2021-09-29 Biocodex Saccharomyces boulardii pour le traitement des troubles de l'humeur
CA3074439A1 (en) 2017-08-30 2019-03-07 Shawn Talbott Nutritional supplements affecting gut-brain-axis balance and mental wellness
CN107712905A (zh) * 2017-11-10 2018-02-23 无比滴(广东)药业有限公司 一种液体益生菌口服液
WO2019098810A2 (ko) * 2017-11-20 2019-05-23 경희대학교 산학협력단 신규 유산균 및 이의 용도
KR102250597B1 (ko) * 2017-11-20 2021-05-11 경희대학교 산학협력단 신규 유산균 및 이의 용도
CA3085508A1 (en) * 2017-12-19 2019-06-27 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
JP2021508321A (ja) * 2017-12-19 2021-03-04 プロバイオティカル・エッセ・ピ・ア 睡眠及び気分障害の治療及び/又は改善における使用のための組成物
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
EP3746096A1 (en) 2018-01-29 2020-12-09 PrecisionBiotics Group Limited Bifidobacterium longum ncimb 41676
WO2019145573A1 (en) * 2018-01-29 2019-08-01 Alimentary Health Limited Bifidobacterium longum ncimb 41676
ES2933999T3 (es) 2018-01-29 2023-02-15 Prec Group Limited Un producto combinado para la profilaxis y el tratamiento del síndrome del intestino irritable
MX2020007987A (es) * 2018-02-02 2020-09-09 Kobiolabs Inc Cepa lactobacillus plantarum kbl396 y uso de la misma.
IT201800003128A1 (it) * 2018-02-28 2019-08-28 Propharma Soc A Responsabilita Limitata Semplificata Composizione probiotica
CN108186688B (zh) * 2018-03-09 2021-03-16 华大精准营养(深圳)科技有限公司 一种促进睡眠的组合物
CN118319957A (zh) 2018-03-28 2024-07-12 森永乳业株式会社 睡眠促进用组合物及使用该睡眠促进用组合物的药物组合物和饮食品组合物
CN108823125A (zh) * 2018-06-13 2018-11-16 山东巴元生物科技有限公司 一种治疗睡眠障碍益生菌制剂的生产方法及应用
CN117487686A (zh) 2018-07-24 2024-02-02 生命大地女神有限公司 选择和使用褪黑素支持细菌以减少婴儿绞痛
CN108949640B (zh) * 2018-08-22 2020-08-04 江南大学 短双歧杆菌ccfm1025、其发酵食品及其应用
EP3866614A1 (en) 2018-10-17 2021-08-25 FrieslandCampina Nederland B.V. Sleep-improving compositions
CN109349645A (zh) * 2018-10-30 2019-02-19 广州普维君健药业有限公司 益生菌组合物、保健食品及其制备方法和应用
CN113194750A (zh) * 2018-12-21 2021-07-30 雀巢产品有限公司 用于在婴儿或幼儿中引起饱腹感、更好的睡眠和/或限制夜间觉醒的营养组合物
US20210352925A1 (en) 2019-02-04 2021-11-18 N.V. Nutricia Fermented formula with non digestible oligosaccharides for sleep improvement
CN111297915B (zh) * 2019-04-12 2021-11-23 首都医科大学附属北京友谊医院 治疗帕金森病快速眼动期睡眠行为障碍的益生菌组合物、制剂及用途
CN110200285A (zh) * 2019-07-23 2019-09-06 河北一然生物科技有限公司 混合益生菌那曲4580(Nagqu 4580)在改善睡眠质量的食品中的应用
CN110339218A (zh) * 2019-08-14 2019-10-18 牛占锋 一种益生菌组合物及其在改善睡眠紊乱中的应用
MX2022002769A (es) * 2019-09-04 2022-07-04 Amare Global Complementos nutricionales y métodos de complementación nutricional que afectan el metabolismo del microbioma.
US11723941B2 (en) 2019-09-04 2023-08-15 Amare Global Nutritional supplements and methods of supplementation affecting the endocannabinoid system
CA3153540A1 (en) 2019-09-04 2021-03-11 Amare Global Nutritional supplements and methods of nutritional supplementation affecting mood and focus in children
US11529387B2 (en) 2019-09-04 2022-12-20 Amare Global Nutritional supplements and methods of nutritional supplementation affecting global mood state
JP6873291B1 (ja) * 2020-02-05 2021-05-19 雪印メグミルク株式会社 睡眠促進用組成物及び組成物を含む食品、医薬品、飼料
CN115299609A (zh) * 2022-03-21 2022-11-08 浙江臻叶茶业有限公司 一种具有改善睡眠功能的组合物及其制备方法
CN115025131B (zh) * 2022-06-02 2023-06-30 广东南芯医疗科技有限公司 罗伊氏乳杆菌e9在制备缓解焦虑、改善睡眠药物中的应用
CN115226773A (zh) * 2022-06-29 2022-10-25 湖北明慧健康科技有限责任公司 一种复合益生菌助眠固体饮料及其制备方法
CN116121130B (zh) * 2022-12-23 2024-10-08 中科宜康(北京)生物科技有限公司 一种提高睡眠质量的复合益生菌发酵组合物及应用
CN116656549B (zh) * 2023-05-25 2023-11-14 微康益生菌(苏州)股份有限公司 一种能够改善睡眠质量的益生菌剂及其应用
CN118576619A (zh) * 2024-08-06 2024-09-03 深圳奥萨制药有限公司 一种含有维生素和矿物质的组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM864894A0 (en) 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
US6444203B2 (en) * 1999-12-20 2002-09-03 Compagnie Gervais Danone Administering bacteria to improve sleep
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US20050100531A1 (en) * 2002-06-13 2005-05-12 John Bienenstock Probiotic therapies
JP4874532B2 (ja) 2004-08-25 2012-02-15 株式会社琉球バイオリソース開発 睡眠改善剤
JP2006160697A (ja) * 2004-12-10 2006-06-22 Kao Corp 睡眠健康改善剤
JP4344827B2 (ja) * 2005-11-28 2009-10-14 国立大学法人九州大学 スキゾキトリウム属の微生物を用いた長鎖高度不飽和脂肪酸含有リン脂質の製造方法
RU2445362C2 (ru) * 2006-02-15 2012-03-20 Нестек С.А. Применение bifidobacterium longum в производстве лекарственного средства или терапевтической питательной композиции для лечения воспалительного заболевания кишечника у млекопитающего и для ослабления воспаления кишечника, связанного с пищевыми аллергенами, у млекопитающего
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
WO2007150052A1 (en) * 2006-06-23 2007-12-27 Equine Research Associates, Ltd Animal nutritional supplement and method
JP2008137941A (ja) 2006-12-01 2008-06-19 Mitsukan Group Honsha:Kk 睡眠改善用組成物
US20080176305A1 (en) * 2006-12-20 2008-07-24 Kikkoman Corporation Functional composition
PL2114423T3 (pl) * 2007-02-28 2012-10-31 Mjn Us Holdings Llc Produkt zawierający unieczynniony probiotyk dla niemowląt
UA28995U (en) 2007-09-24 2007-12-25 Sanitary and hygienic product
EP2110028A1 (en) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression

Also Published As

Publication number Publication date
WO2010060722A1 (en) 2010-06-03
EP2438821B1 (en) 2020-01-15
RU2642301C2 (ru) 2018-01-24
US20140212389A1 (en) 2014-07-31
PH12014501749B1 (en) 2016-01-18
RU2013137772A (ru) 2015-02-20
MY160376A (en) 2017-03-15
PT2438821T (pt) 2020-04-22
CL2012001950A1 (es) 2013-01-11
CN102202527A (zh) 2011-09-28
PH12014501749A1 (en) 2016-01-18
CL2011000891A1 (es) 2011-09-16
EP2352393A1 (en) 2011-08-10
ZA201206546B (en) 2022-03-30
EP2438821A1 (en) 2012-04-11
AU2009319257B2 (en) 2014-10-09
RU2011122453A (ru) 2012-12-10
RU2642301C9 (ru) 2018-06-27
AU2009319257A1 (en) 2010-06-03
MX2011004142A (es) 2011-05-25
ES2771176T3 (es) 2020-07-06
US20110206649A1 (en) 2011-08-25
CN102202527B (zh) 2014-12-31
CA2742476A1 (en) 2010-06-03
RU2517616C2 (ru) 2014-05-27
US9034314B2 (en) 2015-05-19
CN102960447A (zh) 2013-03-13
TW201029583A (en) 2010-08-16
US20140242050A1 (en) 2014-08-28

Similar Documents

Publication Publication Date Title
BRPI0921617A2 (pt) Composicao nutricional compreendendo probioticos e padroes do sono aperfeicoados
ATE488227T1 (de) Feste zubereitung mit alogliptin und pioglitazon
HK1246695A1 (zh) 交聯劑和它們的用途
BRPI1010839A2 (pt) suplemento nutricional oral para crianças compreendendo probióticos
BRPI0922486A2 (pt) microcápsulas e suas respectivas utilizações
GB0718300D0 (en) Microcapsules and methods
IL212852A0 (en) Methods of identifying sleep and waking patterns and uses
IL211042A0 (en) Imidazopyridin-2-one derivatives and uses thereof
EP2291720A4 (en) PROCESSOR ON SLEEP
ZA201103635B (en) Azaquinolinone derivatives and uses thereof
ZA201201407B (en) Nutritional compositions comprising fiber and probiotics
ZA201103456B (en) Leukolectins and uses thereof
EP2291377A4 (en) IMIDAZOPYRIMIDINONE AND ITS USES
EP2309563A4 (en) COMPOSITION AND LIGHT-EMITTING ELEMENT USING THE COMPOSITION
DE112009001910A5 (de) Sleep determination and sleep determination method
GB0800948D0 (en) Infant sleep sling
TWI349319B (en) Structure with embedded circuit and process thereof
BRPI1012696A2 (pt) composicao nutricional compreendendo curminaoides e metodos de fabricacao
EP1972034A4 (en) HEAT COVER PLUG AND CONNECTOR ASSEMBLY WITH ADVANCED CONNECTIVITY FUNCTIONS
BR112012003860A2 (pt) Combinação, e, composição nutricional
EP2305770A4 (en) COMPOSITION AND LIGHT EMITTING ELEMENT COMPRISING THE SAME
IL206951A0 (en) 3-alkyl-piperazine derivatives and uses thereof
BRPI0815579A2 (pt) Tratamento de distúrbio do sono
FI20065416A0 (fi) Probioottinen ravintolisä
GB0822881D0 (en) Puddy and kitty pad

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 35/742 (2015.01), A23L 33/135 (2016.01), A61K

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2485 DE 21-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.